These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 30624764

  • 1. miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer.
    Lv ZD, Xin HN, Yang ZC, Wang WJ, Dong JJ, Jin LY, Li FN.
    J Cell Physiol; 2019 Jul; 234(7):10819-10826. PubMed ID: 30624764
    [Abstract] [Full Text] [Related]

  • 2. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD, Yang DX, Liu XP, Jin LY, Wang XG, Yang ZC, Liu D, Zhao JJ, Kong B, Li FN, Wang HB.
    Cell Physiol Biochem; 2017 Jul; 44(5):1785-1795. PubMed ID: 29216628
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL, Zhang ZJ, Yi ZB, Li JJ.
    Br J Cancer; 2017 Jun 27; 117(1):78-88. PubMed ID: 28571042
    [Abstract] [Full Text] [Related]

  • 4. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ, Zeng HX, Huang P, Wang S, Xie CH, Li SJ.
    Eur Rev Med Pharmacol Sci; 2018 Oct 27; 22(19):6379-6385. PubMed ID: 30338806
    [Abstract] [Full Text] [Related]

  • 5. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 27; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

  • 7. miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
    Xiong H, Yan T, Zhang W, Shi F, Jiang X, Wang X, Li S, Chen Y, Chen C, Zhu Y.
    Cell Signal; 2018 Apr 21; 44():33-42. PubMed ID: 29339084
    [Abstract] [Full Text] [Related]

  • 8. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY, Zheng XH, Deng AP, Wang Y, Liu J, Zhou Q, Cheng GY, Jiang Q.
    Eur Rev Med Pharmacol Sci; 2019 Dec 21; 23(23):10433-10442. PubMed ID: 31841197
    [Abstract] [Full Text] [Related]

  • 9. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
    Zhao M, Zhang M, Tao Z, Cao J, Wang L, Hu X.
    Technol Cancer Res Treat; 2020 Dec 21; 19():1533033820905824. PubMed ID: 32174262
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.
    Wang L, Kang FB, Wang J, Yang C, He DW.
    Anticancer Drugs; 2019 Mar 21; 30(3):225-232. PubMed ID: 30334817
    [Abstract] [Full Text] [Related]

  • 11. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H, Sang M, Liu F, Ai N, Geng C.
    Pathol Res Pract; 2019 Apr 21; 215(4):697-704. PubMed ID: 30611621
    [Abstract] [Full Text] [Related]

  • 12. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J, Lai Y, Ma J, Liu Y, Bi J, Zhang L, Chen L, Yao C, Lv W, Chang G, Wang S, Ouyang M, Wang W.
    BMC Cancer; 2017 Nov 10; 17(1):745. PubMed ID: 29126392
    [Abstract] [Full Text] [Related]

  • 13. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F, Zhuang L, Wu R, Li D.
    J BUON; 2019 Nov 10; 24(5):1905-1912. PubMed ID: 31786854
    [Abstract] [Full Text] [Related]

  • 14. Exploring specific prognostic biomarkers in triple-negative breast cancer.
    Bao C, Lu Y, Chen J, Chen D, Lou W, Ding B, Xu L, Fan W.
    Cell Death Dis; 2019 Oct 24; 10(11):807. PubMed ID: 31649243
    [Abstract] [Full Text] [Related]

  • 15. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G, Wang P, Zhang H.
    J Gene Med; 2019 Dec 24; 21(12):e3129. PubMed ID: 31693779
    [Abstract] [Full Text] [Related]

  • 16. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J, Shin VY, Siu MT, Ho JC, Cheuk I, Kwong A.
    BMC Cancer; 2016 Nov 14; 16(1):887. PubMed ID: 27842518
    [Abstract] [Full Text] [Related]

  • 17. Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer.
    Hu J, Xu J, Wu Y, Chen Q, Zheng W, Lu X, Zhou C, Jiao D.
    Tumour Biol; 2015 Jan 14; 36(1):251-8. PubMed ID: 25238878
    [Abstract] [Full Text] [Related]

  • 18. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
    Xin H, Jiang D, Lü Z, Sun S, Kong J, Li F.
    Zhonghua Yi Xue Za Zhi; 2015 Aug 11; 95(30):2474-7. PubMed ID: 26711213
    [Abstract] [Full Text] [Related]

  • 19. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT.
    Nie J, Jiang HC, Zhou YC, Jiang B, He WJ, Wang YF, Dong J.
    Biosci Biotechnol Biochem; 2019 Jun 11; 83(6):1062-1071. PubMed ID: 30950326
    [Abstract] [Full Text] [Related]

  • 20. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C, Li X, Fan Q, Liu G, Yin J.
    Aging (Albany NY); 2019 Jul 16; 11(14):4858-4875. PubMed ID: 31310241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.